Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.45 |
| ▸ | MDM4 | O15151 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28522099 | 1.00 | CASP3 (0.48) | CASP3KMT2APIN1MDM4TP53 | |
| SCHEMBL31512913 | 0.89 | CASP3 (0.47) | CASP3KMT2APIN1MDM4TP53 | |
| SCHEMBL31098370 | 0.89 | CASP3 (0.47) | CASP3KMT2APIN1MDM4TP53 | |
| SCHEMBL29403817 | 0.88 | CASP3 (0.45) | CASP3KMT2APIN1MDM4TP53 | |
| SCHEMBL21403411 | 0.88 | CASP3 (0.45) | CASP3KMT2APIN1MDM4TP53 | |
| SCHEMBL21432488 | 0.88 | CASP3 (0.45) | CASP3KMT2APIN1MDM4TP53 | |
| SCHEMBL21416088 | 0.88 | CASP3 (0.45) | CASP3KMT2APIN1MDM4TP53 | |
| SCHEMBL21403410 | 0.88 | CASP3 (0.45) | CASP3KMT2APIN1MDM4TP53 | |
| SCHEMBL31098371 | 0.88 | CASP3 (0.45) | CASP3KMT2APIN1MDM4TP53 | |
| SCHEMBL7390390 | 0.88 | CASP3 (0.52) | CASP3KMT2APIN1MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591674-A | Cyclohexapeptide and preparation method and application thereof | 陕西未来多肽生物科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-115232195-A | Oligopeptide two-dimensional nanomaterial and application thereof | 忻州师范学院 | 2022-10-25 | — | — | CN | claimed |
| CN-114948860-A | Supermolecule hydrogel nano material, gelator, preparation method and application thereof | 东南大学 | 2022-08-30 | — | — | CN | claimed |
| CN-102702343-A | Method for synthesizing tesamorelin through solid phases | GL BIOCHEM SHANGHAI CO LTD | 2012-10-03 | — | — | CN | claimed |
| EP-0981556-A1 | ETHYLENE/ALPHA-OLEFIN/DIENE INTERPOLYMERS AND THEIR PREPARATION | THE DOW CHEMICAL COMPANY (US) | 2000-03-01 | — | — | EP | claimed |
| WO-1998049212-A1 | ETHYLENE/ALPHA-OLEFIN/DIENE INTERPOLYMERS AND THEIR PREPARATION | THE DOW CHEMICAL COMPANY (US) | 1998-11-05 | — | — | WO | claimed |
| CN-120192365-A | Colipase inhibiting peptide and application thereof | 宜客美股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-120136974-A | Cyclopentapeptide-4, preparation method thereof and polypeptide cosmetic | 陕西未来多肽生物科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119591674-A | Cyclohexapeptide and preparation method and application thereof | 陕西未来多肽生物科技有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-118356515-A | FAP-targeted conjugate with radionuclide and application thereof | 广州医科大学附属第一医院（广州呼吸中心） | 2024-07-19 | — | — | CN | disclosed |
| US-12012468-B2 | Cyclic polypeptides for PCSK9 inhibition | MERCK SHARP & DOHME LLC (US) | 2024-06-18 | — | — | US | disclosed |
| CN-117720621-B | Alpha-amylase inhibiting peptide and application thereof | 北京晶泰科技有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-118047737-A | Preparation method of amide compound | 湖北师范大学 | 2024-05-17 | — | — | CN | disclosed |
| EP-3345917-A1 | ANTIPROTOZOAL COMPOUNDS | Bacoba AG (CH) | 2018-07-11 | — | — | EP | disclosed |
| US-9605020-B2 | Method for producing dipeptide derivative containing disubstituted amino acid residue | NAGASE & CO., LTD. (JP) | 2017-03-28 | — | — | US | disclosed |
| US-20160362445-A1 | SOLID PHASE PEPTIDE SYNTHESIS VIA SIDE CHAIN ATTACHMENT | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2016-12-15 | — | — | US | disclosed |
| US-20160207958-A1 | METHOD FOR PRODUCING DIPEPTIDE DERIVATIVE CONTAINING DISUBSTITUTED AMINO ACID RESIDUE | NAGASE & CO., LTD. (JP) | 2016-07-21 | — | — | US | disclosed |
| US-9388212-B2 | Solid phase peptide synthesis via side chain attachment | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2016-07-12 | — | — | US | disclosed |
| US-20140235789-A1 | SOLID PHASE PEPTIDE SYNTHESIS VIA SIDE CHAIN ATTACHMENT | CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S.A. (GR) | 2014-08-21 | — | — | US | disclosed |
| CN-102702343-A | Method for synthesizing tesamorelin through solid phases | GL BIOCHEM SHANGHAI CO LTD | 2012-10-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160362445-A1 | SOLID PHASE PEPTIDE SYNTHESIS VIA SIDE CHAIN ATTACHMENT | HDGF, VIP, HDGFL3 | CASP3 4643/4885KMT2A 2268/4885PIN1 1757/4885 |
| US-20140235789-A1 | SOLID PHASE PEPTIDE SYNTHESIS VIA SIDE CHAIN ATTACHMENT | HDGF, VIP, HDGFL3 | CASP3 4643/4885KMT2A 2268/4885PIN1 1757/4885 |
| US-12012468-B2 | Cyclic polypeptides for PCSK9 inhibition | PCSK9, LDLR, PCSK7 | CASP3 2160/4885KMT2A 4061/4885PIN1 1290/4885 |
| US-20160207958-A1 | METHOD FOR PRODUCING DIPEPTIDE DERIVATIVE CONTAINING DISUBSTITUTED AMINO ACID RESIDUE | DNPEP, PEPD, ASNS | CASP3 3125/4885KMT2A 2329/4885PIN1 868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.